John Militello - 14 Oct 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Vice President of Finance, Treasurer, Principal Accounting Officer
Signature
/s/ Martin Wilson, as attorney-in-fact for John Militello
Issuer symbol
RCKT
Transactions as of
14 Oct 2025
Net transactions value
-$114,581
Form type
4
Filing time
16 Oct 2025, 16:01:50 UTC
Previous filing
09 Sep 2025
Next filing
20 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Militello John Vice President of Finance, Treasurer, Principal Accounting Officer C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY /s/ Martin Wilson, as attorney-in-fact for John Militello 16 Oct 2025 0001662170

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale $78,570 -19,841 -21% $3.96 76,083 14 Oct 2025 Direct F1
transaction RCKT Common Stock Sale $21,863 -5,514 -7.2% $3.96 70,569 14 Oct 2025 Direct F1
transaction RCKT Common Stock Sale $11,930 -3,005 -4.3% $3.97 67,564 14 Oct 2025 Direct F1
transaction RCKT Common Stock Sale $2,218 -558 -0.83% $3.98 67,006 14 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.

Remarks:

Vice President of Finance, Treasurer, Principal Accounting Officer